José A. Cruz-Serrano
Research Subjects
Research Interests
José A. Cruz-Serrano has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Daniela Lucero del Carmen Delgado-Lara
Departamento Académico de Formación Universitaria, Ciencias de la Salud, Universidad Autónoma de Guadalajara, Zapopan 45129, Jalisco, Mexico
1 shared publication - Erandis D. Torres-Sánchez
Departamento de Ciencias Medicas y de la Vida, Centro Universitario de la Cienega, Universidad de Guadalajara, Guadalajara 47820, Mexico
1 shared publication - Genaro Gabriel Ortiz
Department of Public Health, Health Science Center University, University of Guadalajara, Guadalajara 44100, Jalisco, Mexico
1 shared publication - Héctor González-Usigli
Mexican Social Security Institute (IMSS), Western National Medical Center (CMNO), Guadalajara 44329, Mexico
1 shared publication - Irma Gabriela Ortiz-Velázquez1 shared publication
- Luis Humberto De Loera Rodríguez
Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS).
1 shared publication
Latest Publications
- Open Access
- 6 February 2019
- Published by IntechOpen
Gut-Brain Axis: Role of Microbiota in Parkinson’s Disease and Multiple Sclerosis
It has recently been discovered that the digestive tract is lined with about 100 million nerve cells; the digestive tract has been baptized, metaphorically speaking, as “the second brain,” which contains a multitude of neurotransmitters, viruses, and bacteria that help regulate our emotional state. This second brain, known as the enteric nervous system, is a unique anatomical unit that extends from the esophagus to the anus. Like the nervous system, it produces a whole series of psychoactive substances, such as serotonin, dopamine, and opioids for pain, and synthesizes benzodiazepines. In it, we find the microbiota: a set of microorganisms (viruses and bacteria). Together with the brain, the microbiota directly influences mood, character, or sleep. Knowledge about the possible relationship of the microbiota with frequent neurological diseases is still just beginning. Recently, possible changes in the microbiota have been linked to the onset of Parkinson’s disease (PD). Also, today, we know that there are differences between the microbiota of healthy people and people with multiple sclerosis and that these differences have also been related to the disease and its evolution.
- 6 February 2019
- Published by IntechOpen
Open AccessGut-Brain Axis: Role of Microbiota in Parkinson’s Disease and Multiple Sclerosis
It has recently been discovered that the digestive tract is lined with about 100 million nerve cells; the digestive tract has been baptized, metaphorically speaking, as “the second brain,” which contains a multitude of neurotransmitters, viruses, and bacteria that help regulate our emotional state. This second brain, known as the enteric nervous system, is a unique anatomical unit that extends from the esophagus to the anus. Like the nervous system, it produces a whole series of psychoactive substances, such as serotonin, dopamine, and opioids for pain, and synthesizes benzodiazepines. In it, we find the microbiota: a set of microorganisms (viruses and bacteria). Together with the brain, the microbiota directly influences mood, character, or sleep. Knowledge about the possible relationship of the microbiota with frequent neurological diseases is still just beginning. Recently, possible changes in the microbiota have been linked to the onset of Parkinson’s disease (PD). Also, today, we know that there are differences between the microbiota of healthy people and people with multiple sclerosis and that these differences have also been related to the disease and its evolution.